According to the websites of these drugs, there are warnings that there may be dose-dependent and treatment duration-dependent risk for C cell tumors at clinically relevant exposures. This has not been studied in humans and, thus far, there are no reports of these findings
February 12, 2024
Saunders, MD, DABOM, the co-founder of Intellihealth and a physician at Weill Cornell Medicine
There's no one "right" way to supplement
Some practitioners implement cycling to theoretically prevent receptor desensitization, provide physiological breaks, or manage costs, though evidence supporting these approaches is limited
Furthermore, significant benefits were observed in functional capacity, with an 18.3-meter increase in the 6-minute walk distance compared to placebo